AKTIPAK Drug Patent Profile
✉ Email this page to a colleague
When do Aktipak patents expire, and when can generic versions of Aktipak launch?
Aktipak is a drug marketed by Biofrontera and is included in one NDA.
The generic ingredient in AKTIPAK is benzoyl peroxide; erythromycin. There are seventeen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the benzoyl peroxide; erythromycin profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for AKTIPAK?
- What are the global sales for AKTIPAK?
- What is Average Wholesale Price for AKTIPAK?
Summary for AKTIPAK
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | AKTIPAK at DailyMed |
US Patents and Regulatory Information for AKTIPAK
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biofrontera | AKTIPAK | benzoyl peroxide; erythromycin | GEL;TOPICAL | 050769-001 | Nov 27, 2000 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
